Drug eruption due to alendronate sodium hydrate

Contact Dermatitis

Volumn 48, Issue 2, 2003, Pages 116-

  Kimura, Mizuho ^a   Kawada, Akira ^b   Murayama, Yukinobu ^a   Murayama, Masaaki ^a  

^a Murayama Hospital   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Alendronate; Cutaneous adverse drug reactions; Positive lymphocye stimulation test; Positive scratch patch test

Indexed keywords

ALENDRONIC ACID; ALFACALCIDOL; BISPHOSPHONIC ACID DERIVATIVE; FOSAMAC;

ABDOMINAL PAIN; AGED; ARTICLE; CASE REPORT; DRUG ERUPTION; ERYTHEMA; ESOPHAGITIS; ESOPHAGUS ULCER; FEMALE; HUMAN; OSTEOPOROSIS; PAPULE; PATCH TEST; PRURITUS;

EID: 0242500853     PISSN: 01051873     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0536.2003.480212_2.x     Document Type: Article

References (4)

1. Russell R G, Rogers M J. Bisphosphonates from the laboratory to the clinic and back again. Bone 1999: 25: 67-106.
2. Gatti D, Adami S. New bisphosphonates in the treatment of bone diseases. Drugs Aging 1999: 15: 285-296.
3. Cummings S R et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures. Results from the fracture intervention trial. JAMA 1998: 280: 2077-2082.
4. Kontoleon P, Ilias I, Stavropoulos P G, Papapetrou P D. Urticaria after administration of alendronate. Acta Derm Venereol 2000: 80: 398.